Concord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...

US demand for H-1B visas has slumped to a seven-year low amid steeper costs and Trump-era policy shifts. This and more in today’s ETtech To...

Warren Buffett divided the investment universe into Inevitables, Highly Probables, and Impostors. The Inevitables are companies whose domin...

SpaceX's huge IPO is set to capture global attention. However, experts believe this event may not reflect the true health of the broader IP...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Happy Thursday! VCs are doubling down on India’s deeptech, with early-stage bets leading the charge. This and more in today’s ETtech Mornin...

Investors are prioritising smaller, early-stage deals in deeptech sectors like AI, healthcare, and precision manufacturing, shying away fro...

Ohio voters have chosen their candidates for key November elections. Billionaire Vivek Ramaswamy will face Dr. Amy Acton for governor. Sena...

Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...

Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...

Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...

Geopolitical tensions in West Asia are manageable now. However, a prolonged US-Israel war against Iran could raise costs for petrochemical-...

Indian equities face rich valuations, prompting investors to look globally. Nikhil Advani of LGT Wealth India highlights opportunities in e...

Global investors are shifting focus from FAANG and Magnificent 7 to broader innovation, embracing the BATMMAAN acronym for AI, semiconducto...

U.S. firms may soon have the option to report earnings semi-annually instead of quarterly, a proposal revived by President Trump. While pro...

A revolutionary synthetic blood is nearing human trials. This freeze-dried product can be stored for years at room temperature. It can be r...

Companies across sectors have resumed IPO roadshows despite Middle East tensions, signalling pent-up demand in the pipeline. Analysts expec...